Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 3-Bromophenol | HCID 11563 | — |
| Reactant | 1,4-Dioxane | HCID 31275 | — |
| Reactant | 2-Methyl-N-[2-(tetrahydro-2H-pyran-2-yl)-6-(4,4,6,6-tetramethyl-1,3,2-dioxaborinan-2-yl)-2H-indazol-4-yl]-1,3-thiazole-4-carboxamide | HCID 58255833 | — |
| Catalyst | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| Solvent | Carbon Dioxide | HCID 280 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | 1,4-Dioxane--water (1/1) | HCID 21886435 | — |
| Product | HCID 44539627 | HCID 44539627 | 5.5% |
Reaction Steps
2-Methyl-N-[2-(tetrahydro-2H-pyran-2-yl)-6-(4,4,6,6-tetramethyl-1,3,2-dioxaborinan-2-yl)-2H-indazol-4-yl]-1,3-thiazole-4-carboxamide (50 mg) and 3-bromophenol (18 mg) were added to a microwave vial. Pd(dppf)Cl2 (8 mg) and 1,4-dioxane (1 ml) were then added. Sodium carbonate (44 mg) in water (1 ml) was added and the reaction was heated under microwave irradiation at 140° C. for 20 min. The reaction was filtered through a 1 g silica SPE cartridge, washing with DCM:MeOH (3:1) then evaporated to dryness. The residue was dissolved in a mixture of DMSO (1.2 ml) and MeOH (0.4 ml) and purified by MDAP (method F). The product-containing fraction was left overnight then evaporated to dryness. The residue was taken up in DCM and a few drops of TFA were added before sonicating the reaction overnight. The residue was dissolved in dioxane/water (1:1, v/v, 2 ml), frozen in cardice and freeze-dried overnight to give the title compound (2 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08163743B2 |
|---|
| Source dataset | uspto-grants-2012_04 |
|---|
| ORD ID | ord-a2486f6323b54ac0874add5c14ace605 |
|---|
| Source note | uspto-grants-2012_04 |
|---|